Escolar Documentos
Profissional Documentos
Cultura Documentos
NEUROMUSCULAR, MUSCULOESQUELÉTICO
E A REABILITAÇÃO Artigo especial
Special article
IMPACTS OF COVID-19 ON THE IMMUNE, NEUROMUSCULAR, AND MUSCULOSKELETAL SYSTEMS Articulo especial
AND REHABILITATION
Keywords: COVID-19; Neuromuscular manifestations; Musculoskeletal system; Exercise therapy; Immune system.
RESUMEN
El nuevo coronavirus, que causa la enfermedad infecciosa llamada COVID-19 por la Organización Mundial de
la Salud, fue notificado en diciembre en China. Las principales manifestaciones clínicas de los pacientes infectados
son fiebre, tos y disnea. Esos pacientes son propensos a desarrollar cambios cardíacos, miopatía difusa, disminución
de la función pulmonar, disminución de la fuerza muscular inspiratoria y deterioro de la capacidad funcional.
Por lo tanto, se espera que los pacientes afectados por COVID-19 sufran secuelas musculoesqueléticas debido
al proceso inflamatorio y pérdida de masa muscular causada por la inmovilidad, que generan discapacidades
motoras aún no son cuantificables. Es necesario comprender las implicaciones clínicas causadas por COVID-19
para elaborar mejores estrategias de rehabilitación para estos pacientes. El objetivo de este estudio fue realizar un
análisis reflexivo sobre el impacto de COVID-19, en los sistemas inmunitario, neuromuscular y musculoesquelético
CONTRIBUIÇÕES DOS AUTORES: Cada autor contribuiu individual e significativamente para o desenvolvimento do manuscrito apresentado. JMG e ACA: revisão crítica do
conteúdo intelectual e aprovação final da versão do manuscrito a ser publicado. GCB: contribuição substancial na concepção do trabalho, revisão crítica do conteúdo intelectual
e aprovação final da versão do manuscrito a ser publicado. MQ e ALSS: contribuição substancial na concepção e redação do trabalho.
REFERÊNCIAS
1. Ashour HM, Elkhatib WF, Rahman MM, Elshabrawy HA. Insights into the recent 2019 novel coronavirus 27. Lechien JR, Chiesa-Estomba CM, De Siati DR, Horoi M, Le Bon SD, Rodriguez A, et al. Olfactory and
(Sars-coV-2) in light of past human coronavirus outbreaks. Pathogens. 2020;9(3):186. gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease
2. Brasil [Ministério da Saúde]. Boletim Epidemiológico 01 - Infecção Humana pelo Novo Coronavírus (COVID-19): a multicenter European study. Eur Arch Oto-Rhino-Laryngology. 2020;2:1–11.
(2019-nCoV) - Janeiro 2020. Bol Epidemiológico. 2020;2:1–17. 28. Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic Manifestations of Hospitalized Patients with
3. Brasil [Ministério da Saúde]. Coronavírus - Plataforma Integrada de Vigilância em Saúde - Ministério da Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020;1–8.
Saúde [Internet]. 2020 [cited 2020 May 21]. Available from: http://plataforma.saude.gov.br/coronavirus/ 29. Dubé M, Coupanec L, Wong AHM, Rini JM, Desforges M, Talbot J. Axonal Transport Enables Neuron-to-
4. Applegate WB, Ouslander JG. COVID-19 Presents High Risk to Older Persons. J Am Geriatr Soc. Neuron Propagation of Human Coronavirus OC43. J Virol. 2018;92(17):1–21.
2020;68(4):681. 30. Baig AM. Neurological manifestations in COVID-19 caused by SARS-CoV-2. CNS Neurosci Ther.
5. Lewnard JA, Lo NC. Scientific and ethical basis for social-distancing interventions against COVID-19. 2020;26(5):499–501.
Lancet Infect Dis. 2020;20(6):631–3. 31. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of
6. Gutiérrez-ocampo E, Villamizar-peña R, Holguin-rivera Y, Franco-paredes C, Henao-martinez AF, Paniz- 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–13.
mondolfi A, et al. Since January 2020 Elsevier has created a COVID-19 resource centre with free information 32. Li YC, Bai WZ, Hirano N, Hayashida T, Hashikawa T. Coronavirus infection of rat dorsal root ganglia:
in English and Mandarin on the novel coronavirus COVID- 19 . The COVID-19 resource centre is hosted Ultrastructural characterization of viral replication, transfer, and the early response of satellite cells.
on Elsevier Connect , the company ’ s public news and information. 2020;34(January). Virus Res. 2012;163(2):628–35.
7. McNeary L, Maltser S, Verduzco-Gutierrez M. Navigating Coronavirus Disease 2019 (Covid-19) in Physiatry: 33. Li YC, Bai WZ, Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory
A CAN report for Inpatient Rehabilitation Facilities. PM R. 2020;12(5):512–5. failure of COVID-19 patients. J Med Virol. 2020;92(6):552–5.
8. Herridge MS, Moss M, Hough CL, Hopkins RO, Rice TW, Bienvenu OJ, et al. Recovery and outcomes 34. Zhou L, Zhang M, Gao J, Wang J. Sars-Cov-2: Underestimated damage to nervous system. Travel Med
after the acute respiratory distress syndrome (ARDS) in patients and their family caregivers. Intensive Infect Dis. 2020;101642.
Care Med. 2016;42(5):725–38. 35. De Felice FG, Tovar-Moll F, Moll J, Munoz DP, Ferreira ST. Severe Acute Respiratory Syndrome Coronavirus
9. Sheehy LM. Considerations for Postacute Rehabilitation for Survivors of COVID-19. JMIR public Heal 2 (SARS-CoV-2) and the Central Nervous System. Trends Neurosci. 2020;1–3.
Surveill. 2020 May 8;6(2):e19462–e19462. 36. Matsuda K, Park CH, Sunden Y, Kimura T, Ochiai K, Kida H, et al. The vagus nerve is one route of transneural
10. Shepherd S, Batra A, Lerner DP. Review of Critical Illness Myopathy and Neuropathy. The Neurohospitalist. invasion for intranasally inoculated influenza A virus in mice. Vet Pathol. 2004;41(2):101–7.
2017;7(1):41–8. 37. Netland J, Meyerholz DK, Moore S, Cassell M, Perlman S. Severe Acute Respiratory Syndrome Coronavirus
11. Madjid M, Safavi-Naeini P, Solomon SD, Vardeny O. Potential Effects of Coronaviruses on the Cardiovascular Infection Causes Neuronal Death in the Absence of Encephalitis in Mice Transgenic for Human ACE2.
System: A Review. JAMA Cardiol. 2020;10:1–10. 2008;82(15):7264–75.
12. Kim JE, Heo JH, Kim HO, Song SH, Park SS, Park TH, et al. Neurological complications during treatment 38. Sedaghat Z, Karimi N. Guillain Barre syndrome associated with COVID-19 infection : A case report. J
of middle east respiratory syndrome. J Clin Neurol. 2017;13(3):227–33. Clin Neurosci. 2020;76:233–5.
13. Tsai LK, Hsieh ST, Chang YC. Neurological manifestations in severe acute respiratory syndrome. Acta 39. Toscano et al. Guillain – Barré Syndrome Associated with SARS-CoV-2. New Engl J Med NEJMc2009191.
Neurol Taiwan. 2005;14(3):113–9. 2020;17–9.
14. Lu M, Yin N, Liu W, Cui X, Chen S, Wang E. Curcumin Ameliorates Diabetic Nephropathy by Suppressing 40. Ichiyama T, Endo S, Kaneko M, Isumi H, Matsubara T, Furukawa S. Serum cytokine concentrations of
NLRP3 Inflammasome Signaling. Biomed Res Int. 2017;2017:1–10. influenza-associated acute necrotizing encephalopathy. 2003;(September 2002):734–6.
15. Shi CS, Nabar NR, Huang NN, Kehrl JH. SARS-Coronavirus Open Reading Frame-8b triggers intracellular 41. K. Chong Ng Kee Kwong, P.R. Mehta, G. Shukla ARM. COVID-19, SARS and MERS: A neurological perspective.
stress pathways and activates NLRP3 inflammasomes. Cell Death Discov. 2019;5(1). J Clin Neurosci. 2020;77:13–6.
16. Deftereos SG, Siasos G, Giannopoulos G, Vrachatis DA, Angelidis C, Giotaki SG, et al. The Greek study in 42. Kansagra SM, Do WBG. Pediatric Neurology Cytokine Storm of Acute Necrotizing Encephalopathy.
the effects of colchicine in COvid-19 complications prevention (GRECCO-19 study): Rationale and study Pediatr Neurol. 2011;45(6):400–2.
design. Hell J Cardiol. 2020;S1109-9666(20):30061–0.
43. Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol.
17. Kelley N, Jeltema D, Duan Y, He Y. The NLRP3 inflammasome: An overview of mechanisms of activation 2020;17(5):259–60.
and regulation. Int J Mol Sci. 2019;20(13):1–24.
44. Poulsen JB. Impaired physical function, loss of muscle mass and assessment of biomechanical properties
18. De Rossi M. Cytokines and chemokines are both expressed by human myoblasts: possible relevance for in critical ill patients. Dan Med J. 2012;59(11):1–21.
the immune pathogenesis of muscle inflammation. Int Immunol. 2000;12(9):1329–35.
45. Mesquita TM de JC, Gardenghi G. Imobilismo e fraqueza muscular adquirida na unidade de terapia
19. Luo G, Hershko DD, Robb BW, Wray CJ, Hasselgren PO. IL-1β stimulates IL-6 production in cultured skeletal intensiva. Rev Bras Saúde Func. 2016;1(3):1–12.
muscle cells through activation of MAP kinase signaling pathway and NF-κB. Am J Physiol - Regul Integr
Comp Physiol. 2003;284(5 53-5):1249–54. 46. Woods J, Hutchinson NT, Powers SK, Roberts WO, Gomez-Cabrera MC, Radak Z, et al. The COVID-19
Pandemic and Physical Activity. Sport Med Heal Sci. 2020;
20. Haddad F, Zaldivar F, Cooper DM, Adams GR. IL-6-induced skeletal muscle atrophy. J Appl Physiol.
2005;98(3):911–7. 47. Mendez-Tellez PA, Nusr R, Needham DM, Feldman D. Early Physical Rehabilitation in the ICU: A Review
for the Neurohospitalist. The Neurohospitalist. 2012;2(3):96–105.
21. Radigan KA, Nicholson TT, Welch LC, Chi M, Amarelle L, Angulo M, et al. Influenza A Virus Infection Induces
Muscle Wasting via IL-6 Regulation of the E3 Ubiquitin Ligase Atrogin-1. J Immunol. 2019;202(2):484–93. 48. Stiller K. Physiotherapy in intensive care: An updated systematic review. Chest. 2013;144(3):825–47.
22. Min A, Baltgalvis KA, Berger FG, Peña MMO, Davis JM, White JP, et al. NIH Public Access. 2010;457(5):989–1001. 49. Kress JP, Hall JB. ICU-acquired weakness and recovery from critical illness. N Engl J Med. 2014;370(17):1626–35.
23. Arentson-Lantz EJ, English KL, Paddon-Jones D, Fry CS. Fourteen days of bed rest induces a decline in satellite cell 50. Barker-Davies RM, O’Sullivan O, Senaratne KPP, Baker P, Cranley M, Dharm-Datta S, et al. The Stanford Hall
content and robust atrophy of skeletal muscle fibers in middle-aged adults. J Appl Physiol. 2016;120(8):965–75. consensus statement for post-COVID-19 rehabilitation. Br J Sports Med. 2020;1–11.
24. Demangel R, Treffel L, Py G, Brioche T, Pagano AF, Bareille MP, et al. Early structural and functional signature 51. Dantas CM, Silva PF dos S, Siqueira FHT de, Pinto RMF, Matias S, Maciel C, et al. Influência da mobili-
of 3-day human skeletal muscle disuse using the dry immersion model. J Physiol. 2017;595(13):4301–15. zação precoce na força muscular periférica e respiratória em pacientes críticos. Rev Bras Ter Intensiva.
25. Drey M, Sieber CC, Bauer JM, Uter W, Dahinden P, Fariello RG, et al. C-terminal Agrin Fragment as a potential 2012;24(2):173–8.
marker for sarcopenia caused by degeneration of the neuromuscular junction. Exp Gerontol. 2013;48(1):76–80. 52. Zhao HM, Xie YX, Wang C. Recommendations for respiratory rehabilitation in adults with COVID-19.
26. Narici M, De Vito G, Franchi M, Paoli A, Moro T, Marcolin G, et al. Impact of sedentarism due to the Chin Med J (Engl). 2020;
COVID-19 home confinement on neuromuscular, cardiovascular and metabolic health: Physiological and 53. Johnston CL, Maxwell LJ, Alison JA. Pulmonary rehabilitation in Australia: A national survey. Physiotherapy.
pathophysiological implications and recommendations for physical and nutritional countermeasures. 2011;97:284–9.
Eur J Sport Sci. 2020;0(0):1–22. 54. Rawal G, Yadav S, Kumar R. Post-intensive care syndrome: An overview. J Transl Intern Med. 2017;5(5):90–2.